Work

Phase 3 study of platinum-based chemotherapy with or without pembrolizumab for first-line metastatic, nonsquamous non-small cell lung carcinoma (NSCLC): KEYNOTE-189.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.tps9104

Authors: Richard Delmar Hall, Shirish M. Gadgeel, Edward B. Garon, Emilio Bria, Martin Reck, John Vida, Honghong Zhou, Harry Raftopoulos, Leena Gandhi

Institutions: University of Virginia, The Barbara Ann Karmanos Cancer Institute, University of California, Los Angeles, University of Verona, German Center for Lung Research, LungenClinic Grosshansdorf, Merck & Co., Inc., Rahway, NJ, USA (United States), Dana-Farber Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2762310076

Cites:

Cited by: 8

Related to: 10